Are you a Canadian innovator and entrepreneur in life sciences or healthcare? Do you have a product or technology you would like to showcase? Are you seeking mentoring and guidance to advance your innovation? Are you a service provider or organization that works with start-ups and entrepreneurs? If yes, then you need to attend the next Health City breakfast and learn more about the 2020 Canada-Chicago Mentoring Program! The Canada Trade Commissioner Service, in partnership with Chicago Innovation Mentors at MATTER.health, is in it’s 6th year of offering the Canada-Chicago Mentoring Program (C2MP), a tailor-made mentoring program focused on life sciences and healthcare innovators working in pharmaceuticals, health IT and medical devices. The 2020 C2MP is operating as a Canadian Technology Accelerator pilot. The program catalyzes the local Chicago life sciences ecosystem to accelerate technology commercialization opportunities in the Chicago area (and the US market) by matching experienced and supportive mentoring teams with early stage innovators. At our breakfast, you’ll hear from Harald Steltzer, Co-Founder and CEO of NoMo Diagnostics Inc. and one of the Chicago Mentors, as well as representatives from the Alberta companies that have participated in the program. Plus, meet Laura Dalby, Consul and Trade Commissioner (Chicago), who manages the program to find out more about the application process and what’s new this year. Laura Dalby works with Chantal Glass, Life Sciences Trade Commissioner in Chicago, to deliver the program. Don’t miss this morning of networking and information! The details: Friday, September 13, 2019 7:00 – 9:30 a.m. Matrix Hotel – Quartz Ballroom 10640-100 Avenue, Edmonton, AB Program: 7:00 – 7:45 Breakfast and networking 7:45 – 9:00 Speakers and panel 9:00 – 9:30 Networking and close The last breakfast event sold out – register now for more details, and to secure your spot! Thank you to Global Affairs Canada Trade Commissioner Service for their support of this event. The speakers: Harald Steltzer, Co-Founder and CEO, NoMo Diagnostics, Inc, Chicago, IL Harald has 25 years of experience building life science product and service companies. He is currently the CEO of NoMo Diagnostics which is developing the first real-time concussion detection system which can be embedded into helmets and headgear. Over the last 5 years, Mr. Steltzer has gained broad exposure to managing early stage life science companies with Boston University and two start-ups, Dohmen Life Science Services and Infinitesimal. Prior to this, he held roles of increasing responsibility in product development and business/corporate development with Abbott, TAP Pharmaceuticals, Schwarz Pharma, and Genzyme. Mr. Steltzer sits on the board of directors for the Illinois Science Council and is member of the Chicago Innovation Mentor program at MatterHealth. He is also an advisor to the launch of a 120,000 sq. ft. life science incubator powered by Sterling Bay in Chicago’s Lincoln Park neighborhood which includes flexible shared wet lab and work space, lab pods and private suites catering to serve biopharma, medtech, diagnostics and life science tool companies. Laura Dalby, CITP®|FIBP® Consul and Trade Commissioner (investment and innovation), Chicago, IL. Laura Dalby manages the Investment and Innovation team at the Consulate General of Canada in Chicago. She supports Canadian starts-up and cross-border investors from Illinois, Missouri, and Wisconsin. She also assists foreign companies planning to invest in Canada and current investors realize the full advantages available through their existing Canadian operations. Laura has worked for the government of Canada for 16 years, with previous postings in Guatemala and Cuba. Laura hails from Vancouver and is passionate about the outdoors. Alberta companies who have participated in the C2MP program: Elsius Health Gauge Umay RunWithIt Synthetics